Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
15
2014
Circuits Split Over Legality of IRS Rule Mandating Tax Credits for Individuals Covered Through Federal Exchanges under the Affordable Care Act Greenberg Traurig, LLP
Aug
15
2014
FDA Releases Guidelines for 12- Year Period of Reference Product Exclusivity for Section 351(a) Biologics Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
13
2014
Biotechnology/Pharma Patents: Immune to Post Grant Challenges? Armstrong Teasdale
Aug
13
2014
Office of Inspector General (OIG) Approves Manufacturer’s Direct-to-Patient Discount Sales Program Mintz
Aug
12
2014
Pharmatech Solutions, Inc. v. LifeScan Scotland Ltd.: Final Written Decision IPR2013-00247 Faegre Drinker
Aug
12
2014
Energy & Environmental Law Update - August 11, 2014 Mintz
Aug
12
2014
Patent Practitioners: Inventions and the Ecosystem of Ideas Womble Bond Dickinson (US) LLP
Aug
12
2014
The Centers for Medicare & Medicaid Services (CMS) Temporarily Closes the Open Payments System Mintz
Aug
12
2014
Health Care Law Update - August 11, 2014 Mintz
Aug
12
2014
Sham Hatch-Waxman Infringement Suits And FDA Citizen Petitions; A Potential For New Liability For Innovators? Sheppard, Mullin, Richter & Hampton LLP
Aug
11
2014
FDA Notifies Congress that It Intends to Regulate Laboratory Developed Tests Barnes & Thornburg LLP
Aug
11
2014
MHRA creates new expert advisory group on medical devices Covington & Burling LLP
Aug
8
2014
FDA Announces Intent to Issue Draft Guidance Documents Describing Regulatory Framework for Laboratory Developed Tests Covington & Burling LLP
Aug
8
2014
Medical Devices: Parallel Claims Against Device Manufacturers post-Riegel? Sills Cummis & Gross P.C.
Aug
8
2014
NLRB’s Sobering Decision Permits Union Representation Before Employee Drug Test Jackson Lewis P.C.
Aug
7
2014
FDA Releases Final Guidance on Expedited Center for Devices and Radiological Health (CDRH) Appeals Barnes & Thornburg LLP
Aug
7
2014
3D-Matrix, Ltd. v. Menicon Co., Ltd., Denying Institution of Inter Partes Review IPR2014-00398 Faegre Drinker
Aug
7
2014
Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation Schwegman, Lundberg & Woessner, P.A.
Aug
6
2014
Anticipated Framework for Regulatory Oversight of Laboratory Developed Tests McDermott Will & Emery
Aug
6
2014
Medical Device Update: FDA Issues Final Guidance on 510(k) Determinations, Use of “Split” Predicates Strongly Discouraged Morgan, Lewis & Bockius LLP
Aug
6
2014
D.C. Circuit Rejects Toxic Tort Claims Based on Aerial Spraying of Herbicide Beveridge & Diamond PC
Aug
5
2014
Summary Of FDA Advertising and Promotion Enforcement Activities Covington & Burling LLP
Aug
5
2014
The Electronic Wallet System: How Nigeria Is Dialing Into Its Agricultural Sector Covington & Burling LLP
Aug
4
2014
Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases Schwegman, Lundberg & Woessner, P.A.
Aug
4
2014
Commission Updates EU Medical Devices Borderline Manual Covington & Burling LLP
Aug
4
2014
FDA Issues Updated Draft Guidance on Reporting Drug Samples Morgan, Lewis & Bockius LLP
Aug
3
2014
EcoWater Systems LLC v. Culligan International Co., Inter Partes Review Still Difficult for Patent Owners McDermott Will & Emery
Aug
3
2014
Dissent at the Patent Trial and Appeal Board (PTAB) Leads to … Unpatentability McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins